<DOC>
	<DOCNO>NCT01463501</DOCNO>
	<brief_summary>This prospective Randomized Phase â…¡ Trial Comparing Preoperative Chemoradiotherapy ( Paclitaxel carboplatin ) Followed Surgery Surgery Followed Postoperative Chemoradiotherapy ( Paclitaxel carboplatin ) Esophageal Cancer .</brief_summary>
	<brief_title>Neoadjuvant Versus Adjuvant Therapy Treating Resectable Thoracic Esophageal Cancer</brief_title>
	<detailed_description>Patient Population : Thoracic esophageal cancer able tolerate tri-modality therapy ; Clinical stage T3-4 , N0-1 , M0 Scheme : Patients randomize 2 arm : Arm A : Paclitaxel/carboplatin concurrent radiation ( 50.4Gy/28f ) follow surgery , consolidate paclitaxel/carboplatin 2 cycle . Arm B : Surgery follow paclitaxel/carboplatin concurrent radiation ( 50.4Gy/28f ) , consolidate paclitaxel/carboplatin 2 cycle .</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Histologically document squamous cell carcinoma adenocarcinoma thoracic esophagus ( &gt; 20cm incisor ) gastroesophageal junction include . No distant metastasis ( M0 ) . Patients stratified stage ( clinical N0 versus clinical N1 ) . Patients tumour within 3 cm distal spread gastric cardia detect esophagogastroscopy . Resectable mediastinal node eligible . No prior chemotherapy malignancy . No prior radiotherapy would overlap field ( ) treat study . Patients malignancy eligible &gt; 5 year without evidence disease completely resect treated nonmelanoma skin cancer . Age &gt; 18 year able tolerate trimodality therapy discretion treat thoracic surgeon , medical radiation oncologist . Tumours must resectable assessment thoracic surgeon . Cancers cervical esophagus ( &lt; 20 cm exclude ) . Tumours &gt; 3 cm spread cardia stomach consider gastric cancer ineligible . Patients biopsy ( endoscopic ultrasound , laparoscopy , laparotomy ) proven metastatic supraclavicular node ineligible . Patients biopsy proven metastatic celiac node ineligible .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Esophageal cancer</keyword>
	<keyword>Resectable</keyword>
	<keyword>Neoadjuvant chemoradiotherapy</keyword>
	<keyword>Adjuvant chemoradiotherapy</keyword>
</DOC>